The reported absence of morphologicafly detectable peroxisomes in liver and kidney tissue cells from patients affected by the autosomic recessive, inherited metabolic disease known as cerebrohepatorenal, or Zeflweger, syndrome was studied in fibroblasts, assuming it to be a generalized defect.
oxidase copurify in subcellular fractionation by differential centrifugation or isopycnic equilibrium in continuous density gradients and peroxidase-positive organelles of =O.1 ,um in diameter are detected in the cytoplasm. In Zellweger cultured fibroblasts, these peroxisomal enzymes are present; however, they behave as cytosolic enzymes in the different subcellular fractionation procedures employed and peroxisomes are not detected cytochemically. These rindings support the hypothesis that the lack of peroxisomes in this genetic disease is the consequence of a defect in the assembly of the peroxisomal constituents. Furthermore, the value offibroblasts for subcellular analysis of peroxisomal defects is illustrated.
Recent evidence supports the hypothesis that in some inherited metabolic disorders, defects in peroxisomal function are pathogenic. The initial observation that peroxisomes are absent in liver and kidney from children affected with the cerebrohepatorenal (Zellweger) syndrome (1) later correlated with the greatly reduced plasmalogen content found in their tissues (2) , a phenomenon attributed to a lack of peroxisomal enzymes involved in plasmalogen biosynthesis (2, 3) . It has also been correlated with the accumulation in fibroblasts of very long-chain fatty acids (4) , supposedly the consequence of a defect in the peroxisomal fatty acid oxidation system capable of oxidizing very long-chain fatty acids (5, 6) . The lack of peroxisomes would also explain the increased blood level of bile acid precursors (7, 8) and possibly of pipecolic acid (9) , assuming it reflects a deficiency in glutaryl-CoA oxidation (10) . Adrenoleukodystrophy constitutes another hereditary disorder in which the accumulation of very longchain fatty acids (11) and also myelin degeneration (12, 13) apparently reflect a peroxisomal defect. As new findings increase the scope of the possible peroxisomal involvement in metabolic inherited disorders, their participation is being considered for hyperpipecolatemia (8, 14) , glutaric aciduria (10) , dicarboxylic aciduria (15, 16) , hyperoxaluria (14, 17) , glycinuria (17) , testicular feminization (18) , and cerebrotendinous xanthomatosis (8, 14) . A single enzymatic defect might explain some of these conditions; however, in the Zellweger syndrome the whole organelle would be missing, perhaps reflecting the deficit of a protein essential for the assembly of peroxisomes. Consequently, as already suggested (14, (19) (20) (21) (22) (23) (24) , this pathologic condition would constitute a unique example of a genetic disorder expressed as absence of a cell organelle involved in cell metabolism.
For macromolecules or subcellular systems normally expressed in fibroblasts, these cells present obvious advantages in the study of genetic defects. Peroxisomes are subcellular organelles, initially recognized morphologically and by subcellular fractionation, defined biochemically by the presence of one or more hydrogen peroxide-generating oxidases and catalase (25) , an association that constitutes an enzymatic system potentially able to sustain peroxidative reactions (26) . Although some peroxisome-related observations have been made in fibroblasts (27) (28) (29) , the physical and biochemical characteristics of these peroxisomes remain largely unknown. To explore the nature of the peroxisomal defect in the Zellweger syndrome we have studied the organization of peroxisomal constituents in fibroblasts obtained from a patient and also in control fibroblasts. Our findings, which have been the subject of a preliminary communication (30) , illustrate the validity of the use of fibroblasts for subcellular studies on the organization of peroxisomes. In addition, they support the proposition that the primary peroxisomal defect in the Zellweger syndrome is expressed as a failure in the assembly of the organelle not in the biosynthesis of its enzymes, or at least some of them.
MATERIALS AND METHODS
Reagents. Fetal calf serum, trypsin, tissue culture media, and supplements were from GIBCO. Percoll and metrizamide were from Pharmacia and Nyegaard (Oslo), respectively. All other reagents were from standard commercial suppliers. Fractionation by Density Gradients. Percoll density gradients of extracts were made according to Merion and Poretz (35) . Briefly, 4.5 ml of extract was layered on top of 25 ml of a Percoll gradient solution, containing 0.25 M sucrose, 1 mM EDTA (pH 7.4), and a 1:3.7 volume dilution of the commercial Percoll solution. A 4-ml cushion of 2.5 M sucrose/10 mM EDTA, pH 7.4, was employed. Centrifugation was carried out in an SV 288 vertical rotor at 18,500 rpm for 1 hr at 4°C in a Sorvall RC-5B rate-controlled centrifuge (DuPont Instruments, Sorvall Division); 1-ml fractions were collected for assays and density measurements according to Rome et al. (32) . Isopycnic metrizamide gradients were made according to Bronfman et al. (36) , with the exception that we used a 25-ml metrizamide gradient with density limits ranging from 1.045 to 1.300 g/ml and a cushion of 4 To further characterize the distribution of the peroxisomal marker catalase, isopycnic fractionation of a postnuclear supernate was performed in Percoll gradients. In normal fibroblasts, excellent resolution was obtained among peroxisomes and lysosomes; this was not so among peroxisomes and mitochondria ( Fig. 2A) . In Zellweger fibroblasts, catalase appeared as a cytosolic enzyme, with only minor differences in the distribution pattern with phosphoglucomutase, probably a reflection of the difference in molecular weights (Fig. 2B) . Catalase does show, however, a minor peak equivalent to 8% of the enzyme at the equilibrium density of peroxisomes.
Isopycnic gradient fractionation was done also with metrizamide as the solute, since Percoll interferes with the fatty acyl-CoA oxidase measurements and the activity in the gradients was already at the lower limit of sensitivity of the method employed for this enzyme. The results, shown in Fig.  3 , confirmed the previous observations for catalase and indicate that the oxidase also has an apparent cytosolic distribution in Zellweger fibroblasts. In control cells catalase displayed a complex distribution. Only a minor fraction followed the soluble marker, whereas an intermediate density peak (1.10-1.14 g/ml), apparently reflected also in the distribution of the fatty acyl-CoA oxidase, raised the possibilities of an adsorption artifact or of a genuine heterogeneous subcellular distribution of these markers.
The fractionation procedures employed are consistent in showing that most, if not all, of the activity ofthe peroxisomal markers in Zellweger fibroblasts behaved as the soluble marker, phosphoglucomutase. The resolution of the methods employed is such that a very reduced peroxisomal population might not be detected unequivocally. The recoveries of enzyme activities in the various fractionation procedures and conditions employed were 79.2% ± 18.1% and 98.5% ± 27.3% for catalase and fatty acyl-CoA oxidase, respectively. These recoveries, though adequate to follow the distribution of the bulk of the marker enzyme, indicated that minor compartments might not be detected. Similar recoveries were observed for the other markers.
Evaluation of the Homogenization Procedures. To further explore the possibility that in Zellweger fibroblasts peroxisomes might be unusually fragile, cells were also disrupted by sonication under conditions that preserve lysosomal and peroxisomal integrity in fibroblasts (data not shown). With the procedures employed, no evidence was found of a major particle-bound catalase fraction in Zellweger fibroblasts. In three independent experiments, after mild sonication, 23 .4% ± 4.8% of the catalase present in IMR-90 fibroblasts was released, whereas, in Zellweger fibroblasts, 93.6% ± 11.1% was found in the supernatant, after centrifugation for 30 min at 100,000 x g. Therefore, the observations after nitrogen pressurization followed by Teflon/glass homogenization, after disruption with the all-glass Dounce homogenizer, and after mild sonication are all consistent with the hypothesis of cytosolic localization for most, if not all, of the activity of the peroxisomal enzymes in Zellweger fibroblasts.
Cytochemical Observations. In control fibroblasts, IMR-90, small organelles of -0.1 gtm in diameter gave positive staining with diaminobenzidine (Fig. 4) in a reaction shown to require H202 in the medium and to be sensitive to inhibition by 3-amino-1,2,4-triazole. Cytochemically positive particles, though not frequent, were easily detected in control fibroblasts; however, we were unable to visualize them unequivocally in Zellweger cells. DISCUSSION According to our data, peroxisomes are present in control human fibroblasts. As controls we employed both primary culture skin fibroblasts and the fibroblast cell line IMR-90. In Zellweger fibroblasts peroxisomes were not detected cytochemically and the peroxisomal marker enzymes cofractionate with phosphoglucomutase, the cytosolic marker. These results indicate that peroxisomes are not detectable in fibroblasts obtained from a Zellweger patient-either by absence, reduced number, or alterations (1)-in spite of the finding that two peroxisomal enzymes are present in these cells, presumably in the cytosol. Their presence in fraction S does not necessarily imply that in intact cells they are free in the cytosol. However, this interpretation is supported by the consistency of the results obtained employing different fractionation procedures. Greatly increased peroxisomal fragility might give a similar result. In fact, liver peroxisomes become larger and more fragile after proliferation (47) , yet some of them, apparently the small ones, resist homogenization. On the whole, the sensitivity of the analytical subcellular fractionation procedures we have employed could not exclude Density (g/ml) the presence of a greatly reduced peroxisomal population. Our cytochemical data are also consistent with the conclusion that peroxisomes are not detectable in this cell line of Zellweger fibroblasts. However, in a recent preliminary communication (48) , the detection of a minor peroxisomal population in the same cell line was reported. That the peroxisomal enzymes are indeed free in the cytosol is further supported by recent data on the differential release, after digitonin treatment, of cytosolic and peroxisomal enzymes from normal and Zellweger fibroblasts (28) . These findings explain the initial description of normal catalase activity in liver homogenates together with the absence of morphologically detectable peroxisomes in Zellweger patients (1) .
The presence of fatty acyl-CoA oxidase and catalase together with the absence of identifiable peroxisomes raises the question of how many of the other peroxisomal proteins (14, 49) fatty acid-oxidizing system (6) . This failure might correspond to the absence of other fatty acid /3-oxidation enzymes or to their inability to operate in a different microenvironment. At least one peroxisomal enzyme, acyl CoA dihydroxyacetonephosphate acyltransferase, an enzyme involved in glycerol ether lipid biosynthesis, is severely deficient in Zellweger fibroblasts (27) , a finding that correlates with the low plasmalogen levels detected in tissues from patients (2) . This enzyme is apparently localized in the organelle membrane (50) . Its deficiency could perhaps indicate that the unique organelle assembly defect characterizing this genetic condition is expressed as absence of peroxisomal membrane. Since the peroxisomal proteins derive from free polysome translation (51, 52) their biosynthesis would be independent of the presence of the membrane. Only their compartmentalization would be prevented. Further studies of peroxisomal constituent biogenesis in Zellweger cells, such as those done in normal liver (51, 52) , would probably contribute to knowledge of the mechanisms of the sorting out of peroxisomal proteins, of the biogenesis of the peroxisomal membrane, and of the critical steps responsible for the assembly of the constituents into a mature organelle. 
